Moneycontrol PRO
HomeNewsAurobindopharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy HDFC Bank, sell Aurobindo Pharma: Sudarshan Sukhani

    According to Sudarshan Sukhani of s2analytics.com, one can buy HDFC Bank and feels that one can sell Aurobindo Pharma.

  • Buy Hexaware, Elgi Equipments; sell Auro Pharma: Mitessh Thakkar

    Buy Hexaware, Elgi Equipments; sell Auro Pharma: Mitessh Thakkar

    Mitessh Thakkar of miteshthacker.com suggests buying Hexaware Technologies, Elgi Equipments and McDowell Holdings and advises selling Aurobindo Pharma.

  • Bull's Eye: Buy United Spirits, HCL Tech; sell Hind Zinc

    Bull's Eye: Buy United Spirits, HCL Tech; sell Hind Zinc

    Ashish Kyal of Waves Strategy Advisors is of the view that one may buy United Spirits with a target of Rs 2510.

  • Invest in private sector banks for long-term, says Dipan Mehta

    Invest in private sector banks for long-term, says Dipan Mehta

    In an interview to CNBC-TV18, Dipan Mehta, Member of BSE & NSE shared his readings and outlook on specific stocks and sector.

  • Like Aurobindo Pharma, Tech Mahindra: Prakash Gaba

    Like Aurobindo Pharma, Tech Mahindra: Prakash Gaba

    Prakash Gaba of prakashgaba.com likes Aurobindo Pharma with target of Rs 725 and Tech Mahindra with target of Rs 500.

  • Buy Aurobindo Pharma, Just Dial: Hemant Thukral

    Buy Aurobindo Pharma, Just Dial: Hemant Thukral

    Hemant Thukral of Aditya Birla Money is of the view that one can buy Aurobindo Pharma for target of Rs 735 as well as Just Dial.

  • Aurobindo Pharma can test Rs 715, HUL Rs 870: Prakash Gaba

    Aurobindo Pharma can test Rs 715, HUL Rs 870: Prakash Gaba

    Prakash Gaba of prakashgaba.com is of the view that Aurobindo Pharma can test Rs 715 while Hindustan Unilever may hit Rs 870.

  • Ashok Leyland can climb to Rs 98, Tata Steel Rs 490: Gaba

    Ashok Leyland can climb to Rs 98, Tata Steel Rs 490: Gaba

    Prakash Gaba of prakashgaba.com is of the view that Ashok Leyland can climb to Rs 98 while Tata Steel may test Rs 490.

  • Buy DCB Bank, L&T, Sintex; sell Auro Pharma: Mitessh Thakkar

    Buy DCB Bank, L&T, Sintex; sell Auro Pharma: Mitessh Thakkar

    Mitessh Thakkar of miteshthacker.com suggests buying DCB Bank, Larsen & Toubro, Sintex Industries and Aarti Industries and advises selling Aurobindo Pharma.

  • Sell Tech Mahindra; buy Yes Bank, Tata Chem, Havells: Sukhani

    Sell Tech Mahindra; buy Yes Bank, Tata Chem, Havells: Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can sell Tech Mahindra and Aurobindo Pharma and buy Yes Bank, Tata Chemicals and Havells India.

  • Buy IndusInd Bk, Bajaj Holdings, M&M; sell Auro Pharma: Thakkar

    Buy IndusInd Bk, Bajaj Holdings, M&M; sell Auro Pharma: Thakkar

    Mitessh Thakkar of miteshthacker.com suggests buying IndusInd Bank, Bajaj Holdings and Mahindra & Mahindra and advises selling Aurobindo Pharma and Dish TV.

  • Buy Chambal Fertilisers, Tata Coffee, Aurobindo Pharma: Gujral

    Buy Chambal Fertilisers, Tata Coffee, Aurobindo Pharma: Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Chambal Fertilisers, Tata Coffee and Aurobindo Pharma.

  • Top buzzing stocks to trade on January 12

    Top buzzing stocks to trade on January 12

    Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today -- Idea Cellular, Sun Pharma, DRL, Lupin, Aurobindo Pharma , Glenmark, Natco Pharma, Alkem Labs, Ajanta Pharma, Strides Shasun, Biocon, Cipla, Cyient, MMTC and Power Grid.

  • Prefer L&T, SBI, Aurobindo Pharma: Shahina Mukadam

    Prefer L&T, SBI, Aurobindo Pharma: Shahina Mukadam

    Shahina Mukadam, Independent Market Expert is of the view that one may prefer Larsen and Toubro, State Bank of India and Aurobindo Pharma.

  • Boosters: 10 stocks that Deutsche Bank is bullish on for 2017

    Boosters: 10 stocks that Deutsche Bank is bullish on for 2017

    Deutsche Bank expects the market to move in a narrow range during 2017, with recovery likely in the latter part of the year. It says unless the union Budget surprises positively with a tax induced fiscal stimulus, the market is likely to mirror the movement seen in Q416.

  • Buy, sell, hold: 21 large & midcap stocks to boost portfolio

    Buy, sell, hold: 21 large & midcap stocks to boost portfolio

    Deutsche Bank‘s midcaps top picks are CESC, Petronet LNG, Ramco Cements, REC, Shriram Transport and UPL. Among top large caps, its picks are Aurobindo, BPCL, Maruti, NTPC, SBI, Shree Cement, Tata Motors, TCS, Tech Mahindra, Vedanta India and YES Bank.

  • Buy MOIL, NMDC: Sudip Bandopadhyay

    Buy MOIL, NMDC: Sudip Bandopadhyay

    Sudip Bandopadhyay, Market Expert is of the view that one can buy MOIL and NMDC even at current level.

  • Buy Reliance Industries, Marico, Adani Ports: Sudarshan Sukhani

    Buy Reliance Industries, Marico, Adani Ports: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com recommends buying Reliance Industries, Marico and Adani Ports.

  • Buy, sell, hold: 11 stocks that analysts are watching out today

    Buy, sell, hold: 11 stocks that analysts are watching out today

    Nomura has a buy ratings on Dr Reddy‘s, Glenmark, Alkem, Cadila and Jubilant Life. It says Teva‘s 2017 guidanceis lower than what was presented in 2016-2020 prelim outlook and implies a shortfall of USD 1.5-2 billion in EBITDA. Teva expects mid-single digit price erosion in the base US business.

  • Here are Deven Choksey's top trading ideas

    Here are Deven Choksey's top trading ideas

    In an interview to CNBC-TV18 Deven Choksey, MD at KRChoksey Investment Managers shared his reading and outlook on the market.

  • Have a look at Tulsian's top bets in cement, pharma & NBFC space

    Have a look at Tulsian's top bets in cement, pharma & NBFC space

    In an interview with CNBC-TV18, SP Tulsian of sptulsian.com gave his stock picks for the day and shared his market outlook.

  • Buy Century Textiles, Aurobindo Pharma, Petronet: Ashwani Gujral

    Buy Century Textiles, Aurobindo Pharma, Petronet: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Century Textiles, Aurobindo Pharma and Petronet LNG.

  • Sell Auro Pharma, REC, Vedanta, HDIL; buy Dabur, TCS: Gujral

    Sell Auro Pharma, REC, Vedanta, HDIL; buy Dabur, TCS: Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one may sell Aurobindo Pharma, REC, Vedanta, Bharat Financial Inclusion and HDIL and buy Dabur India and TCS.

  • Buy EIL, Maruti; sell Aurobindo Pharma, PFC: Ashwani Gujral

    Buy EIL, Maruti; sell Aurobindo Pharma, PFC: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one may buy Engineers India and Maruti Suzuki and sell Aurobindo Pharma, Jubilant Foodworks and PFC.

  • Here is why  SP Tulsian continues to be positive on market

    Here is why SP Tulsian continues to be positive on market

    Despite the recent fall in market, SP Tulsian of sptulsian.com maintains his positive stance on back of expectation of a good Budget.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347